HB 2059 Summary

• Authorized health care providers may prescribe epinephrine auto-injectors in the name of authorized entities (restaurants, recreation camps, youth sports leagues, amusement parks, sports arenas) for emergency use.

• Authorized entities may stock epinephrine auto-injectors and designate trained employees or agents responsible for storage, maintenance, and oversight of the supply.

• Trained employees, agents, or other individuals may provide or administer epinephrine auto-injectors to any person believed to be experiencing anaphylaxis, regardless of prior prescription or allergy diagnosis.

• All individuals providing or administering epinephrine auto-injectors must complete anaphylaxis training from a nationally recognized organization covering symptom recognition, storage and administration standards, and emergency procedures.

• Authorized entities and trained individuals are immune from liability for ordinary negligence in administering or failing to administer epinephrine auto-injectors; entities must report all incidents to the State Department of Health, which publishes annual summaries.

• Act becomes effective November 1, 2015.